Transforming the linkage to care
MagIA diagnostics Point-of-care screening will transform the way patients are linked to care
multiplexed
4 to 8 parameters at once
Broad screening campaigns
fast
Results given in 12 minutes
Just in time for a consultation
small sample
Just 50 µl of capillary blood
Easy to use and non-invasive
portable
A system weight below 3 kg
Get it done wherever needed
Syndromic testing
MagIA diagnostics offers a new approach allowing the screening of HIV and its coinfections hepatitis B and C in a single test using capillary blood. With its ability to test 2 cartridges at the same time, our system to test up to 8 markers at the point of care. Our portable and syndromic approach provides benefits to healthcare professionals allowing more people to be tested in less time, resulting in a better linkage to care of the patients.
One system – endless testing
MagIA diagnostics will offer a large panel of syndromic testing panels – all based on the same analyzer
Analyzer
Disrupting today’s blood-testing standards, the MagIA diagnostic Analyzer brings laboratory quality testing to the Point-of-Care. Compared to lateral flow assay, our device-based approach allows for a simplified and enhanced traceability of patient data. This portable system is designed for effortless and straightforward operation, making it suitable for both medical and non-medical professionals
Non-contractual visuals / Product not CE marked
Non-contractual visuals / Product not CE marked
Latest news
The latest updates from MagIA diagnostics
Le projet MAGFA obtient un financement européen
[hashtag#LBPmember] 📢 Le projet MAGFA reçoit un financement européen de 5 millions d’Euros. Ce projet, accompagné par Lyonbiopôle Auvergne-Rhône-Alpes, est porté par la société MagIA diagnostics en collaboration avec l’Institut Pasteur ainsi que 5 acteurs d’Afrique...
Read our feature on MLFIA to MagIA in SLAS magazine
Read the article “From a research platform (MLFIA) to a multiplexed POC system (MagIA)” in the June issue of SLAS magazine. Thanks to SLAS (Society for Laboratory Automation and Screening) for this highlight. Découvrez l'article : "From a research platform (MLFIA) to...
MAGICIEN clinical study!
EN| Here we go! We are entering Phase 3 of our MAGICIEN clinical study! Thursday, Paul and Damien went to the European Hospital of Marseille to launch this third phase where around 50 patients will be tested. Our goal: to validate the sensitivity and specificity of...
Home
Diagnostics
Life sciences
About us
Contact us
News
Legal Notice
Cookies policy
Log in
Home
Diagnostics
Life sciences
About us
Contact us
News
Legal Notice
Cookies policy
Log in
Home
Diagnostics
Life sciences
About us
Contact us
News
Legal Notice
Cookies policy
Log in
